Health

The use of hormonal contraceptives, particularly levonorgestrel-releasing intrauterine devices (IUDs), has become increasingly prevalent among women of reproductive age. However, emerging research raises vital questions about the potential long-term health risks associated with these contraceptive methods. A recent Danish study has highlighted a substantial link between the use of hormone-releasing IUDs and an elevated risk

The intersection of HIV and organ transplantation has long been a controversial topic, surrounded by stigma and misperceptions. Until the implementation of the HIV Organ Policy Equity (HOPE) Act in 2013, federal regulations prohibited organs from HIV-positive donors to HIV-positive recipients. This legislative change has opened doors to previously unconsidered options for patients suffering from

The landscape of healthcare in the United States is at a critical juncture, particularly with the ongoing challenges associated with the Medicare Physician Fee Schedule (MPFS). A bipartisan coalition in the House of Representatives recently highlighted the urgency of addressing proposed cuts to the MPFS, emphasizing that these reductions threaten not only the livelihood of

In the politically charged atmosphere of an election year, the health status of candidates is often scrutinized as much as their policies. Vice President Kamala Harris’s recent health report, disclosed by her physician Dr. Joshua Simmons, serves as a key document that not only reassures the public about her fitness for office but also casts

In recent discussions surrounding healthcare, several experts have illuminated the multifaceted challenges within the system. Eric Peterson, a prominent cardiologist and member of the FDA advisory committee, shared his concerns regarding the approval processes for new treatments, particularly for rare conditions like Barth syndrome. He likened the decision-making process for such treatments to a gamble,

When Simon reunited with his best friend Andre after months of work-related travel, he was struck by a profound sense of disbelief at Andre’s condition. The physical toll of kidney disease and the harsh realities of dialysis were starkly evident. Andre’s struggle with chronic illness was compounded by the agonizing wait for a kidney transplant;

The recent consideration of elamipretide by the FDA’s Cardiovascular and Renal Drugs Advisory Committee illustrates the complex interplay between the urgent need for therapies in ultra-rare diseases and the rigorous standards of evidence typically required for drug approval. On Thursday, the committee cast a narrow vote in favor of elamipretide’s efficacy as a treatment for

As Hurricane Milton advances towards the southeastern United States, medical supply chains are under siege once again. Federal agencies, along with major medical manufacturers, are in a race against time to safeguard critical hospital supplies. This latest natural disaster threatens to exacerbate an already precarious situation resulting from recent disruptions in IV fluid production when

In recent years, the burgeoning field of regenerative medicine, particularly concerning stem cell therapies, has captured the interest of many seeking relief from chronic ailments and unproven medical conditions. However, this interest has also led to the proliferation of companies marketing dubious stem cell treatments, particularly in regions where regulations have been weak or poorly

The recent announcement from the Biden administration regarding the nationwide initiative to replace lead pipes marks a pivotal moment in American public health policy. With an alarming estimate of over 9 million lead pipes still in operation, the decision to mandate their replacement within the next decade is more than just regulatory—it’s fundamentally about protecting